Europe - Frankfurt Stock Exchange - FRA:93M1 - DE000A289V03 - Common Stock
The current stock price of 93M1.DE is 24.1 EUR. In the past month the price decreased by -6.23%. In the past year, price increased by 2.12%.
ChartMill assigns a technical rating of 7 / 10 to 93M1.DE. When comparing the yearly performance of all stocks, 93M1.DE is one of the better performing stocks in the market, outperforming 79.86% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to 93M1.DE. 93M1.DE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months 93M1.DE reported a non-GAAP Earnings per Share(EPS) of -26.91. The EPS decreased by -196.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -52.66% | ||
| ROE | -56.18% | ||
| Debt/Equity | 0.02 |
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 10.85 | 200.25B | ||
| SNW.DE | SANOFI | 10.63 | 196.17B | ||
| SAN.PA | SANOFI | 10.63 | 196.21B | ||
| MRK.DE | MERCK KGAA | 15.24 | 56.52B | ||
| UNC.DE | UCB SA | 40.61 | 50.71B | ||
| UCB.BR | UCB SA | 41.37 | 51.66B | ||
| 1BAYN.MI | BAYER AG-REG | 7.74 | 40.61B | ||
| BAYN.DE | BAYER AG-REG | 7.77 | 40.79B | ||
| IPN.PA | IPSEN | 13.1 | 11.27B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 113.22 | 10.48B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 24.36 | 10.03B | ||
| VIRP.PA | VIRBAC SA | 20.59 | 3.00B |
MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin and currently employs 2 full-time employees. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.
MPH HEALTH CARE AG KONV
Gruenauer Strasse 5
Berlin BERLIN DE
Employees: 2
Phone: 4930863214560
MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin and currently employs 2 full-time employees. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.
The current stock price of 93M1.DE is 24.1 EUR. The price increased by 0.42% in the last trading session.
MPH HEALTH CARE AG KONV (93M1.DE) has a dividend yield of 5.24%. The yearly dividend amount is currently 0.
93M1.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
MPH HEALTH CARE AG KONV (93M1.DE) operates in the Health Care sector and the Pharmaceuticals industry.
MPH HEALTH CARE AG KONV (93M1.DE) will report earnings on 2026-05-26.